Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Inventory (2020 - 2026)

PROCEPT BioRobotics has reported Inventory over the past 7 years, most recently at $77.5 million for Q1 2026.

  • Quarterly Inventory rose 24.4% to $77.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $77.5 million through Mar 2026, up 24.4% year-over-year, with the annual reading at $70.7 million for FY2025, 25.86% up from the prior year.
  • Inventory was $77.5 million for Q1 2026 at PROCEPT BioRobotics, up from $70.7 million in the prior quarter.
  • Over five years, Inventory peaked at $77.5 million in Q1 2026 and troughed at $12.6 million in Q1 2022.
  • The 5-year median for Inventory is $42.6 million (2023), against an average of $45.7 million.
  • Year-over-year, Inventory surged 209.47% in 2023 and then grew 2.88% in 2024.
  • A 5-year view of Inventory shows it stood at $28.5 million in 2022, then surged by 39.28% to $39.8 million in 2023, then surged by 41.28% to $56.2 million in 2024, then rose by 25.86% to $70.7 million in 2025, then grew by 9.68% to $77.5 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Inventory are $77.5 million (Q1 2026), $70.7 million (Q4 2025), and $66.7 million (Q3 2025).